Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Current Leases of $367000.0 in Q4 2025, up 69.12% quarter-over-quarter from $217000.0 in Q3 2025, and up 14.69% on a YoY basis from $320000.0 in Q4 2024.
Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $367000.0 for Q4 2025.
- In Q4 2025, Current Leases rose 14.69% year-over-year to $367000.0; the TTM figure through Dec 2025 stood at $367000.0 (up 14.69% YoY), while the FY2025 annual figure was $367000.0, up 14.69% from the prior year.
- Current Leases was $367000.0 for Q4 2025 at Dianthus Therapeutics, up from $217000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.6 million in Q3 2022 to a low of $211000.0 in Q2 2025.
- Historically, Current Leases has averaged $992785.7 across 4 years, with a median of $372000.0 in 2024.
- Biggest YoY gain for Current Leases was 19.14% in 2023; the steepest drop was 88.59% in 2023.
- A 4-year view of Current Leases shows it stood at $350000.0 in 2022, then gained by 19.14% to $417000.0 in 2023, then slipped by 23.26% to $320000.0 in 2024, then increased by 14.69% to $367000.0 in 2025.
- The last three Current Leases figures came in at $367000.0 (Q4 2025), $217000.0 (Q3 2025), and $211000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | 367,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 211,000.00 |
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 417,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.25 Mn |